校正因子改善即时检验与实验室INR值的一致性
该研究回顾性评估了即时检验(POC)INR与实验室INR的一致性,发现POC INR>3时一致性较差。通过线性回归得出校正系数0.77,在验证队列中应用校正因子0.8显著提高了POC INR>3的准确性,但未显著减少基于方案的华法林剂量调整差异。
要点
- POC INR与实验室INR在阈值±15%和±25%下一致性分别为51.2%和66.6%。
- POC INR>3时一致性更低,分别为24.9%和44.9%。
- 应用校正因子0.8可显著改善POC INR>3的准确性,但对华法林剂量调整影响不大。
核心结论
- POC与实验室INR结果一致性差,尤其POC INR>3时。
- 应用机构特异性校正因子可改善POC INR>3与实验室INR的一致性。
- 校正因子未显著减少基于方案的华法林剂量调整差异。
研究设计与样本
- 回顾性队列研究,推导队列259例患者344对同日INR结果,验证队列169例患者209对INR结果。
- 采用单变量线性回归推导POC INR>3的校正因子,并在第二队列验证。
主要发现
- 推导队列中,POC与实验室INR在±15%和±25%阈值下一致性分别为51.2%和66.6%。
- POC INR>3(n=205)时一致性分别为24.9%和44.9%。
- 线性回归系数为0.77(95%CI 0.76-0.79;p<0.001)。
- 验证队列中应用校正因子0.8后,POC INR>3的准确性从7%升至71.1%(较低阈值),从23.5%升至88.8%(较高阈值),p<0.0001。
临床怎么用
- 可考虑对POC INR>3的值应用机构特异性校正因子以提高与实验室INR的一致性。
- 但校正因子对基于方案的华法林剂量调整影响有限,需结合临床判断。
局限性
- 回顾性研究设计。
- 单机构研究,校正因子可能不具普适性。
- 未评估校正因子对临床结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Results of a research project to quantify and improve the accuracy of point-of-care (POC) International Normalized Ratio (INR) values are reported. METHODS: The accuracy of POC INR values relative to laboratory-measured INR values was retrospectively assessed in a cohort of patients with same-day INR determinations by both methods. Univariate linear regression was performed to derive a correction factor for POC INR values of >3; this correction factor was validated in a second cohort. RESULTS: In the derivation cohort (259 patients and 344 paired INR results), agreement of POC values with corresponding laboratory INR values at two specified thresholds (±15% and ±25%) was 51.2% and 66.6%, respectively; for POC INR values of >3 (n = 205), agreement was lower (24.9% and 44.9%, respectively). Univariate linear regression yielded a coefficient of 0.77 (95% confidence interval, 0.76-0.79; p < 0.001). Applying a correction factor of 0.8 to POC INR values in a validation cohort (169 patients and 209 paired INR values) significantly improved the accuracy of POC INR values of >3 relative to laboratory values (from 7% to 71.1% at the lower threshold and from 23.5% to 88.8% at the higher threshold, p < 0.0001 for both comparisons). CONCLUSION: Agreement between POC and laboratory INR results in one institution was poor, especially when POC INR values exceeded 3. Application of an institution-specific correction factor to POC INR values of >3 improved agreement with laboratory INR results but would not have significantly reduced differences in protocol-based warfarin dosage adjustments.
引用
- Johnson SA, Vazquez SR, Fleming R, et al. Correction factor to improve agreement between point-of-care and laboratory International Normalized Ratio values. Am J Health Syst Pharm. 2016. PMID: 28007718. doi:10.2146/ajhp150813
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。